 |
 |
 |
 |
 |
 |
|
||||||||||||||
Select publications
Buzdar A et al. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: Long-term safety analysis of the ATAC trial. Lancet Oncol 2006;7(8):633-43. Abstract
Delozier T et al. Delayed adjuvant tamoxifen: Ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial). Ann Oncol 2000;11(5):515-9. Abstract
Goss PE et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17. J Natl Cancer Inst 2005;97(17):1262-71. Abstract
Robert NJ et al. Updated analysis of NCIC CTG MA.17 (letrozole vs placebo to letrozole vs placebo) post unblinding. Proc ASCO 2006;Abstract 550.
| Table of Contents | Top of Page |
Editor:
Neil Love, MD
Interviews
J Michael Dixon, MD
- Select publications
Maura N Dickler, MD
- Select publications
William C Wood, MD
- Select publications
John Mackey, MD
- Select publications
 |
 |
 |
 |
 |
